globoidní leukodystrofie [Leukodystrophy, Globoid Cell]

tematický
16
Termíny

galaktocerebrosidová lipidóza
galaktocerebrosidóza
globoid cell leukodystrofie
globoidní leukodystrofie s pozdním nástupem
globoidní leukodystrofie, infantilní typ
Krabbeho choroba
Krabbeho nemoc s pozdním nástupem
Krabbeho nemoc, infantilní typ
Krabbeova choroba s pozdním nástupem
Krabbeova choroba, infantilní typ
Krabbeova nemoc
leukodystrofie globoidní
leukodystrofie s globoidními buňkami

 

Classic Globoid Cell Leukodystrophy
Diffuse Globoid Body Sclerosis
Early-Onset Globoid Cell Leukodystrophy
Galactocerebrosidase Deficiency
Galactosylceramidase Deficiency Disease
Galactosylceramide beta-Galactosidase Deficiency
Galactosylceramide Lipidosis
Galactosylceramide-beta-Galactosidase Deficiency Disease
Galactosylcerebrosidase Deficiency
Galactosylsphingosine Lipidosis
GALC Deficiency
Globoid Body Sclerosis, Diffuse
Globoid Cell Leukodystrophy
Globoid Cell Leukoencephalopathy
Globoid Leukodystrophy
Infantile Globoid Cell Leukodystrophy
Krabbe Disease
Krabbe Leukodystrophy
Krabbe's Disease
Krabbe's Leukodystrophy
Late-Onset Globoid Cell Leukodystrophy
Leukodystrophy, Globoid Cell, Classic
Leukodystrophy, Globoid Cell, Early-Onset
Leukodystrophy, Globoid Cell, Infantile
Leukodystrophy, Globoid Cell, Late-Onset
Psychosine Lipidosis

Perzistentní odkaz   https://www.medvik.cz/link/D007965
Definice

Krabbeova nemoc, globoid cell leukodystrofie - dědičné onemocnění metabolismu lipidů spočívající v deficitu lyzozomálního enzymu beta-galaktosidázy (galaktocerebrosidáza, galaktosylceramid-beta-galaktosidáza). Dědičnost je autozomálně recesivní (14q21 - q31). Galaktocerebrosidy (galaktosylceramidy) se hromadí v bílé hmotě mozku, dochází k progresivní mozkové degeneraci. Infantilní forma se projeví kolem 3. měsíce života hypertonií, atrofií optiku. Onemocnění progreduje v opistotonus, děti umírají do 3 let. Pozdní infantilní forma onemocnění se manifestuje až kolem 2. roku, klinická symptomatologie je stejná, onemocnění ovšem probíhá mnohem pomaleji. Prognóza je nepříznivá. Syn. galaktocerebrosidóza, galaktocerebrosidová lipidóza. (cit. Velký lékařský slovník online, 2013 http://lekarske.slovniky.cz/ )

An autosomal recessive metabolic disorder caused by a deficiency of GALACTOSYLCERAMIDASE leading to intralysosomal accumulation of galactolipids such as GALACTOSYLCERAMIDES and PSYCHOSINE. It is characterized by demyelination associated with large multinucleated globoid cells, predominantly involving the white matter of the central nervous system. The loss of MYELIN disrupts normal conduction of nerve impulses.

DUI
D007965 MeSH Prohlížeč
CUI
M0012415
Historická pozn.
1974(1963)
Veřejná pozn.
1974; see CEREBRAL SCLEROSIS, DIFFUSE 1963-1973; for LEUKODYSTROPHIES see CEREBRAL SCLEROSIS, DIFFUSE 1963-1973; for KRABBE DISEASE see KRABBE'S DISEASE 1974-1997

C Nemoci
C10.228.140 nemoci mozku 1 177
C10.228.140.163 metabolické nemoci mozku 84
C10.228.140.163.100.362 dědičné demyelinizační nemoci CNS 11
C10.228.140.163.100.362.250 adrenoleukodystrofie 41
C10.228.140.163.100.362.312 Alexanderova nemoc 6
C10.228.140.163.100.362.375 syndrom Canavanové 9
C10.228.140.163.100.362.500 globoidní leukodystrofie 16
C10.228.140.163.100.362.550 metachromatická leukodystrofie 29
C10.228.140.163.100.362.775 Pelizaeusova-Merzbacherova nemoc 11
C10.228.140.163.100.435.825 sfingolipidózy 12
C10.228.140.163.100.435.825.200 Fabryho nemoc 187
C10.228.140.163.100.435.825.250 Farberova nemoc 5
C10.228.140.163.100.435.825.300 gangliosidóza 11
C10.228.140.163.100.435.825.400 Gaucherova nemoc 83
C10.228.140.163.100.435.825.590 globoidní leukodystrofie 16
C10.228.140.163.100.435.825.700 Niemannova-Pickova nemoc 36
C10.228.140.163.100.435.825.775 syndrom histiocytů barvy mořské modři 4
C10.228.140.163.100.435.825.850 sulfatidóza 1
C10.228.140.695 leukoencefalopatie 11
C10.228.140.695.625.250 adrenoleukodystrofie 41
C10.228.140.695.625.312 Alexanderova nemoc 6
C10.228.140.695.625.375 syndrom Canavanové 9
C10.228.140.695.625.500 globoidní leukodystrofie 16
C10.228.140.695.625.550 metachromatická leukodystrofie 29
C10.228.140.695.625.775 Pelizaeusova-Merzbacherova nemoc 11
C10.314.400.250 adrenoleukodystrofie 41
C10.314.400.312 Alexanderova nemoc 6
C10.314.400.375 syndrom Canavanové 9
C10.314.400.500 globoidní leukodystrofie 16
C16.320.565.189.362.250 adrenoleukodystrofie 41
C16.320.565.189.362.312 Alexanderova nemoc 6
C16.320.565.189.362.375 syndrom Canavanové 9
C16.320.565.189.362.500 globoidní leukodystrofie 16
C16.320.565.189.362.550 metachromatická leukodystrofie 29
C16.320.565.189.362.775 Pelizaeusova-Merzbacherova nemoc 11
C16.320.565.189.435.825 sfingolipidózy 12
C16.320.565.189.435.825.200 Fabryho nemoc 187
C16.320.565.189.435.825.250 Farberova nemoc 5
C16.320.565.189.435.825.300 gangliosidóza 11
C16.320.565.189.435.825.400 Gaucherova nemoc 83
C16.320.565.189.435.825.590 globoidní leukodystrofie 16
C16.320.565.189.435.825.700 Niemannova-Pickova nemoc 36
C16.320.565.189.435.825.775 syndrom histiocytů barvy mořské modři 4
C16.320.565.189.435.825.850 sulfatidóza 1
C16.320.565.398.641 lipidózy 35
C16.320.565.398.641.803 sfingolipidózy 12
C16.320.565.398.641.803.300 Fabryho nemoc 187
C16.320.565.398.641.803.325 Farberova nemoc 5
C16.320.565.398.641.803.350 gangliosidóza 11
C16.320.565.398.641.803.441 Gaucherova nemoc 83
C16.320.565.398.641.803.585 globoidní leukodystrofie 16
C16.320.565.398.641.803.730 Niemannova-Pickova nemoc 36
C16.320.565.398.641.803.850 syndrom histiocytů barvy mořské modři 4
C16.320.565.398.641.803.925 sulfatidóza 1
C16.320.565.595.554.825 sfingolipidózy 12
C16.320.565.595.554.825.200 Fabryho nemoc 187
C16.320.565.595.554.825.250 Farberova nemoc 5
C16.320.565.595.554.825.300 gangliosidóza 11
C16.320.565.595.554.825.400 Gaucherova nemoc 83
C16.320.565.595.554.825.590 globoidní leukodystrofie 16
C16.320.565.595.554.825.700 Niemannova-Pickova nemoc 36
C16.320.565.595.554.825.775 syndrom histiocytů barvy mořské modři 4
C16.320.565.595.554.825.850 sulfatidóza 1
C18.452 metabolické nemoci 1 196
C18.452.132.100.362.250 adrenoleukodystrofie 41
C18.452.132.100.362.312 Alexanderova nemoc 6
C18.452.132.100.362.375 syndrom Canavanové 9
C18.452.132.100.362.500 globoidní leukodystrofie 16
C18.452.132.100.362.550 metachromatická leukodystrofie 29
C18.452.132.100.362.775 Pelizaeusova-Merzbacherova nemoc 11
C18.452.132.100.435.825 sfingolipidózy 12
C18.452.132.100.435.825.200 Fabryho nemoc 187
C18.452.132.100.435.825.250 Farberova nemoc 5
C18.452.132.100.435.825.300 gangliosidóza 11
C18.452.132.100.435.825.400 Gaucherova nemoc 83
C18.452.132.100.435.825.590 globoidní leukodystrofie 16
C18.452.132.100.435.825.700 Niemannova-Pickova nemoc 36
C18.452.132.100.435.825.775 syndrom histiocytů barvy mořské modři 4
C18.452.132.100.435.825.850 sulfatidóza 1
C18.452.584.563.641 lipidózy 35
C18.452.584.563.641.803 sfingolipidózy 12
C18.452.584.563.641.803.300 Fabryho nemoc 187
C18.452.584.563.641.803.325 Farberova nemoc 5
C18.452.584.563.641.803.350 gangliosidóza 11
C18.452.584.563.641.803.441 Gaucherova nemoc 83
C18.452.584.563.641.803.585 globoidní leukodystrofie 16
C18.452.584.563.641.803.730 Niemannova-Pickova nemoc 36
C18.452.584.563.641.803.850 syndrom histiocytů barvy mořské modři 4
C18.452.584.563.641.803.925 sulfatidóza 1
C18.452.648.189.362.250 adrenoleukodystrofie 41
C18.452.648.189.362.312 Alexanderova nemoc 6
C18.452.648.189.362.375 syndrom Canavanové 9
C18.452.648.189.362.500 globoidní leukodystrofie 16
C18.452.648.189.362.550 metachromatická leukodystrofie 29
C18.452.648.189.362.775 Pelizaeusova-Merzbacherova nemoc 11
C18.452.648.189.435.825 sfingolipidózy 12
C18.452.648.189.435.825.200 Fabryho nemoc 187
C18.452.648.189.435.825.250 Farberova nemoc 5
C18.452.648.189.435.825.300 gangliosidóza 11
C18.452.648.189.435.825.400 Gaucherova nemoc 83
C18.452.648.189.435.825.590 globoidní leukodystrofie 16
C18.452.648.189.435.825.700 Niemannova-Pickova nemoc 36
C18.452.648.189.435.825.775 syndrom histiocytů barvy mořské modři 4
C18.452.648.189.435.825.850 sulfatidóza 1
C18.452.648.398.641 lipidózy 35
C18.452.648.398.641.803 sfingolipidózy 12
C18.452.648.398.641.803.300 Fabryho nemoc 187
C18.452.648.398.641.803.325 Farberova nemoc 5
C18.452.648.398.641.803.350 gangliosidóza 11
C18.452.648.398.641.803.441 Gaucherova nemoc 83
C18.452.648.398.641.803.585 globoidní leukodystrofie 16
C18.452.648.398.641.803.730 Niemannova-Pickova nemoc 36
C18.452.648.398.641.803.850 syndrom histiocytů barvy mořské modři 4
C18.452.648.398.641.803.925 sulfatidóza 1
C18.452.648.595.554.825 sfingolipidózy 12
C18.452.648.595.554.825.200 Fabryho nemoc 187
C18.452.648.595.554.825.250 Farberova nemoc 5
C18.452.648.595.554.825.300 gangliosidóza 11
C18.452.648.595.554.825.400 Gaucherova nemoc 83
C18.452.648.595.554.825.590 globoidní leukodystrofie 16
C18.452.648.595.554.825.700 Niemannova-Pickova nemoc 36
C18.452.648.595.554.825.775 syndrom histiocytů barvy mořské modři 4
C18.452.648.595.554.825.850 sulfatidóza 1